Stability Challenges in High-Concentration Biologic Formulations
Traditional intravenous biologics often require long infusion times and healthcare provider supervision. High-concentration formats allow for:
Click to read the full article.
Stability Testing for Biopharmaceuticals
pH and Ionic Strength in Biologic Drug Stability
The stability of biologics is governed by a delicate balance of electrostatic and hydrophobic interactions. Altering the pH or ionic strength can shift this balance, potentially leading to:
Click to read the full article.
Stability Testing in Biologic Scale-Up and Manufacturing
Biologic drugs are particularly sensitive to process changes. As production moves from laboratory or pilot scale to full-scale manufacturing, changes in:
Click to read the full article.
Microbial Contamination Risks in Biologic Stability Testing
Biologic drugs, especially injectables and parenterals, are highly susceptible to microbial intrusion due to their aqueous formulations, complex storage requirements, and sensitive molecular structures. Contamination during stability testing can lead to:
Click to read the full article.
Temperature Excursions and Interpreting Biologic Stability Data
A temperature excursion occurs when a product is exposed to temperatures outside its labeled storage range for any duration. Examples include:
Click to read the full article.
Container Selection and Compatibility in Biologic Stability Studies
Biologics often come in injectable dosage forms requiring direct contact with primary packaging materials. If the material is incompatible, it can lead to:
Click to read the full article.
Stability Protocol Design for Biosimilar Comparability
Regulatory agencies such as the USFDA, EMA, and CDSCO require biosimilar manufacturers to demonstrate that their product remains stable and comparable to the reference product throughout its lifecycle. Stability studies support:
Click to read the full article.
Stability Challenges in Biologic Combination Products
Combination products integrate a biologic drug with a device or delivery system. Common examples include:
Click to read the full article.
Long-Term vs Accelerated Stability Testing in Biopharmaceuticals
Biologic products are highly sensitive to environmental factors such as temperature, humidity, light, and mechanical stress. Instability can result in:
Click to read the full article.
Stability Assessment in Biopharmaceutical Formulation Development
Biologic molecules—such as monoclonal antibodies, peptides, and fusion proteins—are inherently unstable due to their complex structure. During formulation development, they are exposed to varying pH levels, ionic strengths, surfactants, and containers. Each component and condition can affect:
Click to read the full article.